Zithromax в суспензии инструкция по применению

zithromax в суспензии инструкция по применению
Типовая клинико-фармакологическая статья #RegDos Casey JR, Pichichero ME. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.Clin Infect Dis. 2005; 40 (12): 1748-55. Применение антибиотиков у детей в амбулаторной практике. Gastrointestinal: Dyspepsia, constipation, anorexia, enteritis, flatulence, gastritis, jaundice, loose stools and oral moniliasis. Although rare, fatalities have been reported. (See CONTRAINDICATIONS .) Despite initially successful symptomatic treatment of the allergic symptoms, when symptomatic therapy was discontinued, the allergic symptoms recurred soon thereafter in some patients without further azithromycin exposure.

Weight 200 mg/5 mL Total mL perTreatment Course Total mg perTreatment Course Kg Lbs. Each child received active drug, and placebo matched for the comparator. Nervous System: Convulsions, dizziness/vertigo, headache, somnolence, hyperactivity, nervousness, agitation and syncope. Циклоспорин: некоторые из макролидных антибиотиков влияют на метаболизм циклоспорина. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by ZITHROMAX (azithromycin) or other antibacterial drugs in the future.

Виды, которые приобретают резистентность в единичных случаяхАэробные грамположительные бактерии — Streptococcus pneumoniae – с промежуточной чувствительностью к пенициллину, пенициллинрезистентный. Description ZITHROMAX (azithromycin tablets and azithromycin for oral suspension) contain the active ingredient azithromycin, an azalide, a subclass of macrolide antibiotics, for oral administration. For the 305 subjects who were evaluated at Test of Cure, the clinical success rate was 75% for both azithromycin and the comparator. In the safety analysis, the incidence of treatment-related adverse events, primarily gastrointestinal, was 16.8% with azithromycin, and 22.5% with the comparator.

Похожие записи: